Original Article
Copyright ©2014 Baishideng Publishing Group Inc.
World J Hepatol. Jun 27, 2014; 6(6): 426-434
Published online Jun 27, 2014. doi: 10.4254/wjh.v6.i6.426
Table 1 Patient cohort
nGender
AgeALTBilirubinCreatininePTWBCLiverOutcome
MaleFemalemean ± SD(10-50 IU/L)(< 17 μmol/L)(45-110 μmol/L)(8-12 s)(4.3-10.8 ×109 cells/L)failure1
8036 (45%)44 (55%)38.7 ± 14.15112 ± 3492118 ± 96181 ± 13652 ± 349.96 ± 6.5147 (58.8%)SWOTX 54 (67.5%) SWTX 11 (18.3%) Died 15 (13.8%)
Table 2 Prevalence of patient
DiagnosisPODAcute viral hepatitisAutoimmune hepatitisPost LTX graft nonfunctionFatty liver of pregnancyMalignancyDILIAcute porphyriaIschaemic hepatitis
Prevalence64 (80%)61 (7.5%)3 (3.75%)2 (2.5%)1 (1.25%)1 (1.25%)1 (1.25%)1 (1.25%)1 (1.25%)
Table 3 Hepatitis E virus immunoglobulin M positive patients
Patient IDGenderAgeLiver function tests (normal range)
HEV
Travel historyInitial/Outcome
ALTBillirubinALPGamma GTPAlbuminPTIgGIgMRNAGenotyperetrospective
(10-50 IU/mL)(< 17 μmol/L)(40-125 IU/L)(5-35 IU/mL)(30-50 g/L)(8-12 s)(IU/mL)(IU/mL)diagnosis
1Female58364892540480351648.4+6.4 × 1043Spain, CornwallDILI/hepatitis ESurvived
2Female6798516256Icteric1191436.49+1.4 × 1033SpainAlcohol, T2Diabetes, obesity, CLD/hepatitis EDied
3Male275288140186368273524.7+--LondonPOD/hepatitis ESurvived
4Male274044269253Icteric1382542.05+1.9 × 1041IndiaHepatitis ESurvived